Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-31

FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves the original application for the generic topical combination Nystatin and Triamcinolone Acetonide by Lupin Pharmaceuticals for fungal infections of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin and Triamcinolone Acetonide (Nystatin and Triamcinolone Acetonide)

Snippet

ORIG AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)